# Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers

> **NCT02264158** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 149 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Telmisartan high
- **DRUG:** Telmisartan low
- **DRUG:** Lacidipine high
- **DRUG:** Lacidipine low
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02264158
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2002-03
- **Final completion:** —
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2014-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264158, "Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02264158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*